【ChiCTR2000031929】Can dermatological tarcolimus 0.1 % ointment be used for treatment of spring catarrh what is its efficacy and safety profile
ChiCTR2000031929
结束
/
/
/
2020-04-15
/
/
春季角膜结膜炎
Can dermatological tarcolimus 0.1 % ointment be used for treatment of spring catarrh what is its efficacy and safety profile
Comparison of efficacy of dermatological 0.1% tacrolimus in treatment on vernal keratoconjunctivitis
52250
Tacrolimus has been used in different concentrations for ophthalmic use. It is used in 0.1 % as well as in 0.03% concentrations. Some studies claim it is more effective in 0.1 % concentration. In most studies tacrolimus is studied in bid dose, we intend to check its efficacy in HS dose.
单臂
上市后药物
N/A
N/A
No funding
/
50
/
2019-07-01
2020-03-31
/
Inclusion criteria were all the pediatric patients of severe VKC, unmanageable with conventional treatment (anti-histamines/mast cell stabilizers/NSAIDS/steroids) or patients showing recurrence after discontinuation of steroids or having steroid-induced complications.；
请登录查看Exclusion criteria were any coexisting ocular disorders such as conjunctival or corneal diseases, ocular infections, uveitis, Stevens Johnson syndrome, contact lens usage, history of ocular surgery. Informed consent was taken and all the patients were explained about the study.；
请登录查看Self-sponsored
52250
Self-sponsored的其他临床试验
- Total thyroidectomy versus Total thyroidectomy with prophylactic central compartment neck dissection in early papillary thyroid cancer
- Can dermatological tarcolimus 0.1 % ointment be used for treatment of spring catarrh what is its efficacy and safety profile
- EFFECTIVENESS OF DISTANCE INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS IN KHYBER PUKHTUNKHWA, PAKISTAN
巴基斯坦古吉兰瓦拉医学院的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10